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This retrospective study includes 139 infants (74 girls and 65 boys) treated for status epilepticus at two University hospitals in
Tunisia between 1990 and 1997. Their mean age was 11 months. The majority of seizures were generalized (74%) and lasted
between 30 minutes and 1 hour (70%). The cause of status epilepticus was classified as acute symptomatic in 56, febrile in 57,
remote symptomatic in nine, progressive neurologic in 10 and idiopathic in seven. Overall mortality was 15.8% and neurological
sequelae were identified in 36% of the cases during the mean follow-up time of 3.5 years. The incidence of significant sequelae
was a function of aetiology (especially acute symptomatic causes) and age (under 1 year of age).
We conclude that the most frequent causes of infantile status epilepticus in Tunisia were fever and acute symptomatic causes.
Status epilepticus among infants is an important public health problem, with significant associated mortality and morbidity.
Management of status epilepticus can be improved by more rapid access to appropriate medical care.
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INTRODUCTION
Status epilepticus is considered to be a common neu-
rologic emergency requiring immediate intervention
to prevent permanent injury to the brain. It is more
frequent in young children and elderly adults, al-
though patients of all ages may experience prolonged
seizures. Status epilepticus occurs in a variety of
conditions especially in children (infections), patients
with previously established epilepsy, cerebral malfor-
mations, hypoxia, hypoglycaemia and head trauma. In
developed countries, reported mortality and morbidity
of status epilepticus in children has declined during the
1980s and 1990s1–5; however, in developing countries
the mortality associated with status epilepticus is still
between 5–7% in children, and there is a high inci-
dence of neurological sequelae6, 7.
In developing countries, very few studies have been
carried out to delineate the particular features of this
disease in the area. So we find it interesting to report
on 139 cases of status epilepticus in a paediatric
population (under 24 months of age) in Tunisia in
whom we investigated the clinical aspects, mortality
and incidence of sequelae.
PATIENTS AND METHODS
We reviewed the medical records of 139 patients who
were admitted to the paediatric unit of two University
Hospitals (Farhat Hached in Sousse and Children
Hospital in Tunis (Tunisia)) between January 1990
and December 1997. Infants 1–24 months of age who
had an episode of status epilepticus were identified
and followed up. We defined status epilepticus as any
continuous seizure lasting longer than 30 minutes or
a series of seizures during which the patient failed to
regain consciousness for at least 30 minutes. The esti-
mated duration of status epilepticus included the time
before arrival at hospital and the time required under
treatment in hospital to bring the seizures under con-
trol. EEG monitoring was rarely available in Tunisia.
The treatment protocol for status epilepticus consisted
of four consecutive steps: (1) rectal diazepam at
0.5 mg kg−1 or IV diazepam at 0.3 mg kg−1, followed
if this failed by; (2) diazepam at 0.3 mg kg−1 or
clonazepam at 0.1 mg kg−1 or phenobarbital at 15–
20 mg kg−1, followed if this failed by; (3) a combined
treatment (clonazepam + phenobarbital, or phenobar-
bital + clonazepam), and if this also failed followed
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by; (4) thiopentone sodium. Phenytoin was not avail-
able in Tunisia. Seizures were classified according to
the international classification as generalized (tonic,
tonic–clonic, or clonic, absence), or partial (simple,
complex, or partial with secondary generalization)
(Commission on Classification and Terminology of
the International League against Epilepsy 1981). The
classification of the seizure type was based on a com-
bination of reported history, observed seizure mani-
festations and sometimes EEG data (30 infants/139).
Seizures were classified by aetiology using the defini-
tions of Maytal et al.4 as: febrile (provoked seizures in
which the sole acute provocation was fever); acute
symptomatic (a seizure occurring during an acute
illness in which there was a known neurologic insult or
systemic metabolic dysfunction); remote symptomatic
(a seizure occurring without acute provocation in a
patient with a prior history of CNS insult known to
be associated with an increased risk of convulsions
(e.g. presence of static encephalopathy or meningitis);
progressive encephalopathy (seizure occurring at any
point during a progressive neurologic disease); or
idiopathic (seizure occurring in the absence of an acute
precipitating CNS insult, or a systemic metabolic
dysfunction, or both). Follow-up consisted of periodic
clinic visits with neurologic evaluation. Cognitive
function was assessed by mental status testing as
a part of a neurodevelopmental examination; no
formal intelligence quotient testing was done. The
mean follow-up was 4 years (range: 2–8 years). The
significance of differences between categories of main
variables was calculated by using the χ2 test, and P
values under 0.05 were considered significant.
RESULTS
1. Age
One hundred and thirty-nine infants (74 girls and
65 boys) were included in the study. Their mean age at
the time of status epilepticus was 11 months. Eighty-
six cases (62%) occurred in the first year of life. The
age distribution as a function of aetiology is shown
in Fig. 1. Over 90% of infants younger than 1 year
had status epilepticus of febrile or acute symptomatic
origin, whereas remote symptomatic causes were most
common in older infants (χ2 = 17.25, P = 0.0001).
2. Pre-hospital treatment
Only seven of the 139 infants (5%) had received an
unspecified dose of rectal diazepam before arrival at
hospital. The mean duration of the presenting convul-
sion prior to arrival to hospital was 40 (range: 30–360)
minutes.
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Fig. 1: Infants with status epilepticus: age distribution and
cause.
3. Prior seizures
Fourteen subjects (10%) had a history of earlier unpro-
voked seizures: seven infants (two with status epilepti-
cus) were in the remote symptomatic and progressive
encephalopathy groups. Seven infants had previously
had febrile convulsions.
4. Seizure type
The majority of seizures (74%) were generalized. Par-
tial status epilepticus occurred in 31 cases (22%), 13 of
which were simple partial, 14 complex partial and four
with secondary generalization. However, partial status
epilepticus types might have been under-diagnosed.
Five children (4%) had seizures that were unclassifi-
able based on available information. Seizure type var-
ied with aetiology. Of infants with a history of febrile
status, 91% had a generalized seizure, compared with
55% of infants in the acute symptomatic group.
5. Duration of status epilepticus
The duration of status epilepticus was known in
121 cases: for 85 patients (70%) seizures lasted be-
tween 30 minutes and 1 hour, for 26 (21.5%) be-
tween 1 and 6 hours, for seven (5.7%) between 6 and
24 hours, and for three (2.8%) it lasted over 24 hours.
The distribution of prolonged seizures as a function
of aetiology is shown in Table 1. Status epilepticus
lasting over 1 hour affected 19 of the 49 patients with
symptomatic aetiology while it involved only seven of
the 49 cases induced by fever, and none in the idio-
pathic group. Thus, the duration of status epilepticus
Infantile status epilepticus in Tunisia 367
was significantly related to aetiology (χ2 = 18.95,
P = 0.000077).
Table 1: Duration of status epilepticus.
<1 hour 1–6 h >6 h Estimate Total
Acute symptomatic 30 13 6 7 56
Febrile 42 7 0 8 57
Remote symptomatic 3 3 2 1 9
Progressive encephalopathy 4 3 2 1 10
Idiopathic 6 0 0 1 7
Total 85 26 10 18 139
Table 2: Aetiology of status epilepticus.
Cause Total %
Febrile 57 41
Acute symptomatic 51 40
CNS infection 26
Metabolic 14
Stroke/Haemorrhage 8
Anoxia 3
Intoxication 3
Head trauma 2
Progressive encephalopathy 10 7
Sturge–Weber syndrome 2
Metabolic/Genetic 8
Remote symptomatic 9 6
Prior CNS insult 7
Brain malformation 2
Idiopathic 7 6
6. Hospital treatment
The first dose of diazepam (rectal or IV) aborted status
epilepticus in 20 patients (14.5%). Only an additional
five children stopped convulsing after a second dose
of diazepam. Those not responding to the second dose
(114 infants) then received clonazepam, or phenobar-
bital, or both drugs, or thiopentone sodium. The results
of treatment are summarized in Fig. 2.
7. Aetiology
A small number of patients (18%) had progressive
encephalopathy, or a remote symptomatic or idio-
pathic cause. The remaining cases were almost equally
distributed among the febrile and acute symptomatic
groups (Table 2). Twenty-six infants suffered from
CNS infection, the majority of which were bacterial
in origin (21 infants) due to Haemophilus influen-
zae (17 patients) or Streptococcus pneumoniae (four
patients). The other five infants suffered from herpes
simplex encephalitis.
Study population
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Seizure stopped
N = 29
Seizure stopped
N = 43
Clonazepam
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Clonazepam
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Phenobarbital
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Phenobarbital
N = 1 7
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Thiopentone sodium
N = 5
Fig. 2: Summary of treatment results of the 139 patients.
8. Outcome
Sixty-seven (48%) infants totally recovered. Twenty-
two (15.8%) infants died within 2 months of the
episode of status epilepticus. In 15 (68%) of them, an
acute cause was identified, including nine cases with
central nervous system (CNS) infection, four cases
with metabolic disorders, one case with severe anoxia,
and one with haemorrhagic stroke. There was only one
death among the 57 infants with febrile status epilep-
ticus. Fifty (36%) infants sustained neurological se-
quelae; including epilepsy without mental retardation
(seven cases), moderate mental retardation (16 cases)
and severe mental retardation with seizures (27 cases).
The distribution of sequelae (mortality and morbidity)
as a function of aetiology is shown in Table 3. The
incidence of significant sequelae was a function of ae-
tiology. It declined from 68% (13/19) in infants with
remote symptomatic and progressive encephalopathy
to 41% (23/56) in the acute symptomatic group and
20% (13/64) in the febrile and idiopathic groups. The
incidence of significant sequelae was also a function
of age of occurrence of status epilepticus. It declined
from 50% (42/88) among infants under 1 year to 16%
(8/51) in infants between 1 and 2 years old.
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Table 3: Mortality and morbidity of status epilepticus.
Death Recovery Seizures Moderate Severe mental Total
mental retardation retardation + seizures
Acute symptomatic 15 18 5 6 12 56
Febrile 1 44 2 6 4 57
Progressive encephalopathy 3 1 6 10
Remote symptomatic 2 3 4 9
Idiopathic 1 5 1 7
Total 22 67 7 16 27 139
DISCUSSION
Most reported series of status epilepticus concerned
the whole range of childhood; there is only one
large series dealing with status epilepticus in infants8.
The striking findings in this study were the variety
of aetiologies and outcome of status epilepticus in
a developing country. Fever and acute symptomatic
causes were the most common aetiologies of status
epilepticus in our series, accounting for 81% of all
cases. An acute cause was found in half of the patients.
The majority of CNS infections were bacterial in
origin (21 patients), due to H. influenzae (17 patients)
or S. pneumoniae (four patients). This condition is still
frequent in Tunisia. In some countries, the invasive
disease caused by H. influenzae type B has been
practically eliminated thanks to vaccination; however,
in most of the developing world, meningitides caused
by these bacteria continue to be a major cause of
childhood morbidity and mortality, as well as high
hospitalization costs. Metabolic disorders are common
in developing countries because dehydration, mal-
nutrition and rickets remain frequent. Seizures due
to metabolic imbalance are often more responsive
to electrolyte correction than to antiepileptic drug
administration.
In comparison with Dulac et al.’s8 original review
of status epilepticus in infants and Phillips et al.9
(children under 3 years of age), we found an increased
incidence of status epilepticus due to fever (41% vs.
25% vs. 30%). This could be secondary to a better
control of fever in developed countries. The role of
febrile seizures in cryptogenic status epilepticus and
in the occurrence of neurological damage after cryp-
togenic febrile status is still less clear. Maytal et al.4
found no deaths and only three children with static
encephalopathies following an episode of febrile sta-
tus epilepticus. In comparison, Aicardi and Chevrie1
have reported a significant morbidity associated with
febrile status epilepticus in the child under 3 years
of age. More recently, Van Esch11 noted neurological
sequelae in 24% of children after febrile status epilep-
ticus (nine children with speech deficit and three with
severe neurological sequelae and epilepsy). It was of
some interest to us that in seven infants (6%) status
epilepticus developed without obvious cause (vs. 17%
of Aubourg et al.’s10 study). In some of these cases, an
anoxic-ischaemic event was suggested by the history,
the seizure and EEG characteristics, and clinical and
neuro-imaging evolution.
The significant relations between age, aetiology,
duration, and major neurological sequelae of sta-
tus epilepticus in this study are in accordance with
previous clinical studies. Status epilepticus is more
common in younger patients and often is the child’s
first seizure. The frequency of acute causes, which
are often treatable, is higher in younger children. In
older children, chronic seizure disorders prevail and
acute reversible systemic conditions are less com-
mon. Maytal et al.4 noted that neurological sequelae
occurred in 29% of infants younger than 1 year of
age, in 11% of children 1–3 years of age, and in 6%
of children older than 3 years. Shinnar et al.12 also
found that age is strongly correlated to the frequency
and aetiology of status epilepticus. In young children,
status epilepticus occurs primarily in children who are
neurologically normal (21%) and with no history of
unprovoked seizures (20%). In older children, status
epilepticus occurs primarily in those who are known
to have prior unprovoked seizures (64%) and who are
often neurologically abnormal (55%).
Recent reports suggest that mortality and morbidity
from status epilepticus may have decreased in recent
years1–6. This improvement is attributed principally to
aggressive management protocols13–15. In our study,
22 (15.8%) infants died within 3 months of having the
seizure. New neurological deficits were found in 50
(36%) of the 117 survivors. In Tunisia, delay in the
diagnosis of acute causes and the rarity of paediatric
intensive care units may explain the high mortality and
morbidity figures. Pre-hospital seizure duration (30–
360 minutes) is also an important factor to consider
in this country. The late admission to hospital is
due to great distances to reach hospitals and/or the
failure of the parents to realize the seriousness of
the child’s symptoms. Although without a population-
based study, our study may have over-estimated mor-
bidity and mortality rates in status epilepticus. In a
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series of infants studied by Dulac et al.8 between
1982 and 1984, 20 out of 79 (25%) infants died and
35 others (44%) were left with permanent neurological
disorders. This very high figure is likely to reflect a
selection bias as it involved an intensive care unit as
a tertiary reference centre. However, Maytal et al.4
reported between 1985 and 1987 a mortality rate of
3% and morbidity of 9%. In the series of Ericks-
son et al.5, neurological sequelae secondary to status
epilepticus were identified in 15% of the cases and,
subsequent epilepsy in 23%, but there were was no
status epilepticus-related deaths.
This series has the limitations of a retrospective
study. It shows, however, that the aetiological spec-
trum of infantile status epilepticus in Tunisia is fever
and acute symptomatic causes (mainly CNS infec-
tion). Mortality and morbidity from status epilepticus
in our country can be improved by more rapid access
to appropriate medical care, by more accessibility to
rectal diazepam in the community prior to arriving
at a hospital and by introducing a conjugate vac-
cine against H. influenzae into the regular vaccina-
tion regimen.
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